Among the paired sample analyses that was performed with 11,123 samples in 23 cancers, ICOS mRNA expression was increased in BRCA, HNSC, KIRC, STAD (all p < 0.001) and ESCA (p < 0.05) and KIRP (p < 0.01). Here, ICOS is linked to cancer.